Following the statement made by Alize Cornet, the Tennis Anti-Doping Programme (TADP) confirms the following:

Ms. Cornet has been charged with a violation of TADP Article 2.4 (Failing three times in any 12-month period…to be available for Testing at the declared whereabouts in accordance with Article I.4 of the International Standard for Testing and Investigations (a “Missed Test”)).

Ms. Cornet was charged with the above violation on 11 January 2018.

In accordance with the TADP rules, no further comment will be made pending determination of the case, except as may be necessary to respond to public comment by Ms. Cornet or her representatives. In that regard, the TADP points out that, contrary to the implication in Ms. Cornet’s statement that the ‘valuable reasons’ for her unavailability for testing at her declared whereabouts went unheard, the process set out in the International Standard for Testing and Investigations for the management of Whereabouts Failures, which includes the right for the player to request an independent assessment of whether the requirements for such failures were met, was followed in all three instances.

The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www. itftennis.com/antidoping.